StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3036% above fair value
$461.26−4.19 (-0.90%)

Close on Nov 3, 2026Market cap $249.37BP/E 28.6Yield 2.09%

Amgen RSUs Vested During Year (M shares) by Year

RSUs Vested During Year (M shares) (M)

Amgen RSUs Vested During Year (M shares): 1.20M in FY2025, down 25.0% from a year earlier.

Latest, FY2025
1.20
Period ended Dec 31, 2025
Change on a year earlier
-25.0%
1.60 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Stock-Based Compensation Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRSUs Vested During Year (M shares) (M)Year on yearSource
FY2025Dec 31, 20251.20-25.0%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20241.60+23.1%Form 10-K (filed 2025-02-14) ↗
FY2023Dec 31, 20231.30+44.4%Form 10-K (filed 2024-02-14) ↗
FY2022Dec 31, 20220.900.0%Form 10-K (filed 2023-02-09) ↗
FY2021Dec 31, 20210.90-10.0%Form 10-K (filed 2022-02-16) ↗
FY2020Dec 31, 202010.0%Form 10-K (filed 2021-02-09) ↗
FY2019Dec 31, 20191-16.7%Form 10-K (filed 2020-02-12) ↗
FY2018Dec 31, 20181.20-20.0%Form 10-K (filed 2019-02-13) ↗
FY2017Dec 31, 20171.50-25.0%Form 10-K (filed 2018-02-13) ↗
FY2016Dec 31, 20162-25.9%Form 10-K (filed 2017-02-14) ↗
FY2015Dec 31, 20152.70–Form 10-K (filed 2016-02-16) ↗

Breakdown

What makes up RSUs Vested During Year (M shares)

Cite this data

StockData. (2026). Amgen RSUs Vested During Year (M shares) (M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/rsu-vest-sh

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.

See a number that looks wrong?